CompletedNot Applicable

Tranexamic Acid for the Prevention of Blood Loss in High Risk Delivered Women

Iraq196 participantsStarted 2020-02-01

Plain-language summary

Postpartum hemorrhage and its complications are very well known causes for maternal mortality .Uterine atony is the most common cause for postpartum hemorrhage

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥ 18 year. * Planed vaginal delivery * Grand multiparity * Twin pregnancy * Polyhydramnios * Previous history of PPH * Macrosomic baby * Prolonged labour * HELLP syndrome * Using of low-molecular weight heparin and Asprin during pregnancy. * Vaginal birth after Cesarean section Exclusion Criteria: * Intrauterine death. * History of thromboembolic disease * Current or previous history of heart disease ,renal and liver disorders * History of seizure or epilepsy * Placenta previa * Placental abruptio

What they're measuring

The amount of vaginal blood loss in the third and fourth stages (the fourth begins with delivery of the placenta and ends 2 hours after delivery)

Timeframe: From the time of injection and up to 2 hours after delivery

Trial details

NCT IDNCT04201951

SponsorHawler Medical University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-10-10

View on ClinicalTrials.gov More Postpartum Hemorrhage trials